Education Osteo-Pharma and Emultech Announce Joint Venture to Develop First-in-Class Disease-Modifying Treatment for Osteoarthritis AMSTERDAM, November 17, 2021 (Newswire.com) – Emultech and Osteo-Pharma today announced a… ReportWireNovember 17, 2021 View Post